Event Details
Zoom Meeting
28 November 2024
12:30pm - 1:30pm AEDT
28 November 2024
– 28 November 2024
Zoom Meeting
28 November 2024
12:30pm - 1:30pm AEDT
28 November 2024
– 28 November 2024
Presenters:
Sarah MelovClinical Midwife Consultant & MFM Research Midwife
Westmead Hospital
Sarah is a CMC & Women’s Health Research MFM at Westmead Hospital. She is a member of the executive team for the Reproduction and Perinatal Centre, Faculty Medicine and Health, The University of Sydney. She is also in the leadership team for the Sydney Health Partners Clinical Academic Group for Reproductive, Maternal and Newborn Health. She is a PhD student focusing on cardiometabolic risk factors during the peripartum period, and has an interest in research translation, consumer involvement in research and understanding the needs of a culturally diverse population with a particular focus on breastfeeding and reducing the risk of diabetes.
Amy (Hei Yee) Tang
Clinical Midwife Consultant
Westmead Hospital
Amy is a Clinical Midwife Consultant at the Women's Health Clinic at Westmead Hospital. She has a clinical background working in continuity of care models. Her interest lies in building continuity within all maternity models of care to improve women's and midwives' experiences and outcomes.
Event Dates
Date: 28 November 2024
Time: 12:30pm – 1:30pm AEDT
Date: 28 November 2024 – 28 November 2024
Location
Zoom Meeting
Supplementing with Folic Acid
Clinical Educators
Zoom Meeting
About
Who isn't taking folic acid in early pregnancy and what can we do about it?
General advice and public health messaging on pregnancy folic acid supplementation continues however, little is known of groups in Australia at risk of low folic acid use. Investigators will discuss the importance of folic acid supplementation before and in early pregnancy. The recent findings investigating folic acid use in a large culturally diverse Australian cohort will be presented. The discussion will be open to look at ways to understand barriers to appropriate supplementation with folic acid and how we can improve targeted messaging.
Folic acid (FA) supplementation before and in early pregnancy is known to improve outcomes such as reducing neural tube defects.
In a large cohort (n= 48,045) we will discuss the groups who were less likely to report folic acid supplementation in early pregnancy and the findings that overall, nearly 40% did not report taking folic acid.
Reassuringly women with type 1 or type 2 diabetes were more likely to report folic acid supplementation than the background population.
